Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0MN9K
|
|||
| Drug Name |
Meclofenamate Sodium
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Arthritis [ICD-11: FA20] | Approved | [1] | |
| Company |
Parke Davis Div Warner Lambert Co
|
|||
| Structure |
 |
Download2D MOL
|
||
| Formula |
C14H10Cl2NNaO2
|
|||
| Canonical SMILES |
CC1=C(C(=C(C=C1)Cl)NC2=CC=CC=C2C(=O)[O-])Cl.[Na+]
|
|||
| InChI |
1S/C14H11Cl2NO2.Na/c1-8-6-7-10(15)13(12(8)16)17-11-5-3-2-4-9(11)14(18)19;/h2-7,17H,1H3,(H,18,19);/q;+1/p-1
|
|||
| InChIKey |
OGPIIGMUPMPMNT-UHFFFAOYSA-M
|
|||
| CAS Number |
CAS 6385-02-0
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:6711
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
| REF 2 | Role of COX-2-derived metabolites in regulation of the renal hemodynamic response to norepinephrine. Am J Physiol Renal Physiol. 2001 Nov;281(5):F975-82. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.